|
EMD1214063
Chemical Information
M.Wt
492.57
Storage
Please store the product under the reco...
More>>
|
|
|
LY2801653
Chemical Information
M.Wt
552.53
Storage
Please store the product under the reco...
More>>
|
|
|
MK-8033
Chemical Information
M.Wt
471.53
Storage
Please store the product under the reco...
More>>
|
|
|
BMS777607
Description of:BMS777607
BMS777607 is a Small-Molecule Met Kinase Inhibitor with an IC50 of < 0.1 μM. Its treatment had little effect on ...
More>>
|
|
|
INCB28060
Description of:INCB28060
Oral dosing of INCB28060 results in time- and dose-dependent inhibition of c-MET phosphorylation and tumor growth in c...
More>>
|
|
|
Foretinib(GSK1363089)
Description of:Foretinib(GSK1363089)
GSK1363089 (XL880)is an orally bioavailable,small molecule MET/VEGFR2 inhibitor with potential antineoplas...
More>>
|
|
|
MGCD-265
Description of:MGCD-265
MGCD265 is a tyrosine kinase inhibitor that targets the MET, VEGFR-1, VEGFR-2, VEGFR-3, RON and TIE2 receptor tyrosine ...
More>>
|
|
|
PHA-665752
Description of:PHA-665752
M.Wt:641.61
Formula:C32H34Cl2N4O4S
Solubility:Soluble to 100 mM in DMSO
Purity:>98 %
S...
More>>
|
|
|
SU-11274
Description of:SU-11274
SU11274 is a highly specific inhibitor of c-Met , with in vitro IC50 for the Met enzyme at 0.012 umol/L.
...
More>>
|
|
|
SGX523
Description of:SGX523
SGX-523, an orally bioavailable small molecule, specifically binds to c-Met protein, or hepatocyte growth factor receptor...
More>>
|
|